2023
DOI: 10.52768/2766-7820/2552
|View full text |Cite
|
Sign up to set email alerts
|

Acute reversible fulminant hepatitis associated with rifampicin

Prashant N Chhajed

Abstract: Tuberculosis in India contributes to significant endemicity, morbidity and mortality. Rifampicin is the most potent bactericidal drug used as a first line agent in the Anti-Tubercular Treatment (ATT) in rifampicin sensitive cases. Adverse effects of the ATT add to morbidity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 10 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?